Received Jan 7, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC15 | PNEUMO (VAXNEUVANCE) | MERCK & CO. INC. | 1 | Z009838 | OT / LA |
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | 1 | — | — |
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | 2 | — | — |
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | 3 | — | — |
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | 4 | — | — |
patient did not report any symptoms / no additional AE; an inadvertent administration of an extra dose of VAXNEUVANCE to a patient; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On unknown dates since birth, the patient completed 4-dose series of pneumococcal 13 valent vaccine (PCV-13), administered for prophylaxis (strength, dose, route of administration, anatomical location, lot# and expiration dates were not reported). On 05-JAN-2026, the patient was inadvertently vaccinated with an extra dose of pneumococcal 15-valent conjugate vaccine (VAXNEUVANCE) suspension for injection, dose 1, strength: 0.5 mL, at a total dose of 0.5 mL, administered intramuscularly in left deltoid, lot #Z009838, expiration date: 17-JUL-2027), for prophylaxis (Extra dose administered). The patient did not report any symptoms (No adverse event).